Loading
Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Status |
|---|---|---|
| 1 | Accepted-Technical | Accepted-Technical Offer technically acceptable |
| 2 | Accepted-Technical CIPLA HOUSE PENINSULA BUSINESS PARK GANPATRAO KADAM MARG LOWER PAREL MUMBAI MAHARASHTRA 400013 | MUMBAI | MAHARASHTRA | 400013 | Accepted-Technical Offer technically acceptable |
| 3 | Accepted-Technical 202 AGARWAL PLAZA PLOT NO 3 DDA COMPLEX SECTOR 14 PRASHANT VIHAR ROHINI 85 NEW DELHI DELHI INDIA 110085 | NEW DELHI | NORTH WEST DELHI | DELHI | 110085 | Accepted-Technical Offer technically acceptable |
| 4 | Accepted-Technical | Accepted-Technical Offer technically acceptable |
Tender Value
Refer Docs
Closing Date
17 Feb 2026, 3:30 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
JAY KUMAR
BHEL MAIN HOSPITAL HARIDWAR
MIRABEGRON 25MG EXTENDED RELEASE TABLET
2026_BHEL_58073_1
205 H/ MDX/5/0205S2
Limited
Drugs and Pharmaceutical Products
Supply
120 days
BHEL MAIN HOSPITAL HARIDWAR
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
Exempted
10 Mar 2026
6 Feb 2026
17 Feb 2026
6 Feb 2026
17 Feb 2026
6 Feb 2026
MIRABEGRON 25MG EXTENDED RELEASE TABLET
stage.html
html • 0.02 MB
tech_eval.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.02 MB
Techno_Commercial_Bid_and_STC_Format_Rev03.pdf
Tender Documents • 0.19 MB
BOQ_62768.xls
BOQ • 0.28 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .